Eyal Lewin

Eyal Lewin has a diverse work experience, primarily in executive leadership roles in the healthcare and technology industries. Eyal is currently the Chief Executive Officer at NYX Technologies, where they focus on merging sleep and science. Before joining NYX Technologies, they served as the CEO of DeveloPro, supporting healthcare companies in entering the German market and finding strategic partners. Eyal also worked as the Marketing and Business Development professional at Epitomee Medical from January 2021 to October 2022.

In the past, Eyal held the CEO position at Insuline Medical, an Israeli medical device company specializing in insulin therapy. Eyal successfully developed and marketed the company's flagship product, the InsuPad. Prior to that, Eyal served as the CEO of KnockNLock and SHL Telemedizin. In the role of CEO at SHL Telemedizin, they oversaw the development and provision of telemedicine solutions for individuals and healthcare professionals.

Eyal's work experience also includes their position as an Advanced Solutions Expert at comverse, where they were involved in advanced technology solutions. Overall, Eyal Lewin's career has been characterized by their leadership roles in the healthcare and technology sectors, focusing on innovation, market expansion, and strategic partnerships.

Eyal Lewin obtained a Bachelor's degree in Management and Economics from Tel Aviv University, where they studied from 1992 to 1995.